HKMPF
Price
$23.96
Change
-$2.42 (-9.17%)
Updated
Aug 11 closing price
Capitalization
5.38B
IRWD
Price
$1.03
Change
-$0.04 (-3.74%)
Updated
Aug 15 closing price
Capitalization
167.31M
81 days until earnings call
Interact to see
Advertisement

HKMPF vs IRWD

Header iconHKMPF vs IRWD Comparison
Open Charts HKMPF vs IRWDBanner chart's image
Hikma Pharmaceuticals
Price$23.96
Change-$2.42 (-9.17%)
Volume$300
Capitalization5.38B
Ironwood Pharmaceuticals
Price$1.03
Change-$0.04 (-3.74%)
Volume$1.29M
Capitalization167.31M
HKMPF vs IRWD Comparison Chart in %
Loading...
HKMPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IRWD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HKMPF vs. IRWD commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HKMPF is a Hold and IRWD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 18, 2025
Stock price -- (HKMPF: $23.60 vs. IRWD: $1.03)
Brand notoriety: HKMPF and IRWD are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: HKMPF: 193% vs. IRWD: 79%
Market capitalization -- HKMPF: $5.38B vs. IRWD: $167.31M
HKMPF [@Pharmaceuticals: Generic] is valued at $5.38B. IRWD’s [@Pharmaceuticals: Generic] market capitalization is $167.31M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.3B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HKMPF’s FA Score shows that 1 FA rating(s) are green whileIRWD’s FA Score has 1 green FA rating(s).

  • HKMPF’s FA Score: 1 green, 4 red.
  • IRWD’s FA Score: 1 green, 4 red.
According to our system of comparison, IRWD is a better buy in the long-term than HKMPF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HKMPF’s TA Score shows that 3 TA indicator(s) are bullish while IRWD’s TA Score has 5 bullish TA indicator(s).

  • HKMPF’s TA Score: 3 bullish, 4 bearish.
  • IRWD’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, IRWD is a better buy in the short-term than HKMPF.

Price Growth

HKMPF (@Pharmaceuticals: Generic) experienced а -9.16% price change this week, while IRWD (@Pharmaceuticals: Generic) price change was +14.84% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +6.26%. For the same industry, the average monthly price growth was +68.76%, and the average quarterly price growth was +80.82%.

Reported Earning Dates

IRWD is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+6.26% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HKMPF($5.38B) has a higher market cap than IRWD($167M). IRWD has higher P/E ratio than HKMPF: IRWD (92.69) vs HKMPF (14.35). HKMPF YTD gains are higher at: 1.199 vs. IRWD (-76.749). HKMPF has more cash in the bank: 127M vs. IRWD (108M). IRWD has less debt than HKMPF: IRWD (599M) vs HKMPF (1.31B).
HKMPFIRWDHKMPF / IRWD
Capitalization5.38B167M3,223%
EBITDAN/A60.1M-
Gain YTD1.199-76.749-2%
P/E Ratio14.3592.6915%
RevenueN/A318M-
Total Cash127M108M118%
Total Debt1.31B599M218%
FUNDAMENTALS RATINGS
HKMPF vs IRWD: Fundamental Ratings
HKMPF
IRWD
OUTLOOK RATING
1..100
8913
VALUATION
overvalued / fair valued / undervalued
1..100
9
Undervalued
80
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
87100
PRICE GROWTH RATING
1..100
8039
P/E GROWTH RATING
1..100
9511
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HKMPF's Valuation (9) in the null industry is significantly better than the same rating for IRWD (80) in the Pharmaceuticals Other industry. This means that HKMPF’s stock grew significantly faster than IRWD’s over the last 12 months.

HKMPF's Profit vs Risk Rating (100) in the null industry is in the same range as IRWD (100) in the Pharmaceuticals Other industry. This means that HKMPF’s stock grew similarly to IRWD’s over the last 12 months.

HKMPF's SMR Rating (87) in the null industry is in the same range as IRWD (100) in the Pharmaceuticals Other industry. This means that HKMPF’s stock grew similarly to IRWD’s over the last 12 months.

IRWD's Price Growth Rating (39) in the Pharmaceuticals Other industry is somewhat better than the same rating for HKMPF (80) in the null industry. This means that IRWD’s stock grew somewhat faster than HKMPF’s over the last 12 months.

IRWD's P/E Growth Rating (11) in the Pharmaceuticals Other industry is significantly better than the same rating for HKMPF (95) in the null industry. This means that IRWD’s stock grew significantly faster than HKMPF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HKMPFIRWD
RSI
ODDS (%)
Bullish Trend 3 days ago
32%
Bearish Trend 3 days ago
65%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
44%
Bearish Trend 3 days ago
77%
Momentum
ODDS (%)
Bearish Trend 3 days ago
31%
Bullish Trend 3 days ago
64%
MACD
ODDS (%)
Bearish Trend 3 days ago
30%
Bullish Trend 3 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
29%
Bullish Trend 3 days ago
71%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
39%
Bullish Trend 3 days ago
67%
Advances
ODDS (%)
N/A
Bullish Trend 5 days ago
66%
Declines
ODDS (%)
N/A
Bearish Trend 3 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
39%
Bearish Trend 3 days ago
68%
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
56%
View a ticker or compare two or three
Interact to see
Advertisement
HKMPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IRWD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TWN48.300.35
+0.73%
Taiwan Fund
LOCT23.88N/A
N/A
Innovator Premium Income 15 Buf ETF -Oct
APUE39.23-0.10
-0.26%
ActivePassive U.S. Equity ETF
CPAI36.11-0.14
-0.37%
Counterpoint Quantitative Equity ETF
COIW43.24-1.08
-2.44%
Roundhill COIN WeeklyPay ETF

HKMPF and

Correlation & Price change

A.I.dvisor indicates that over the last year, HKMPF has been loosely correlated with EBS. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if HKMPF jumps, then EBS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HKMPF
1D Price
Change %
HKMPF100%
N/A
EBS - HKMPF
34%
Loosely correlated
+0.23%
IRWD - HKMPF
22%
Poorly correlated
-3.74%
AMPH - HKMPF
22%
Poorly correlated
-1.26%
GRUSF - HKMPF
8%
Poorly correlated
-3.00%
HYPMY - HKMPF
7%
Poorly correlated
+4.58%
More

IRWD and

Correlation & Price change

A.I.dvisor tells us that IRWD and BGPPF have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IRWD and BGPPF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRWD
1D Price
Change %
IRWD100%
-3.74%
BGPPF - IRWD
24%
Poorly correlated
N/A
AMPH - IRWD
23%
Poorly correlated
-1.26%
DVAX - IRWD
22%
Poorly correlated
+1.60%
HKMPF - IRWD
22%
Poorly correlated
N/A
EOLS - IRWD
22%
Poorly correlated
+5.16%
More